Zhengye Biotechnology Holding (ZYBT) Retained Earnings (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Retained Earnings for 3 consecutive years, with -$3.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Retained Earnings fell 145.5% year-over-year to -$3.1 million in Q4 2025; TTM through Dec 2025 was -$3.1 million, a 145.5% decrease from a year earlier, with the FY2025 full-year figure at -$3.1 million, down 146.98% from the prior year.
• Retained Earnings was -$3.1 million for Q4 2025 at Zhengye Biotechnology Holding, down from $3.7 million in the prior quarter.
• Over five years, Retained Earnings peaked at $6.7 million in Q4 2024 and troughed at -$3.1 million in Q4 2025.
• A 3-year average of $3.2 million and a median of $4.5 million in 2025 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings advanced 25.75% in 2024 and tumbled 145.5% in 2025, its largest moves.
• Over 3 years, Retained Earnings stood at $5.3 million in 2023, then advanced by 25.75% to $6.7 million in 2024, then plunged by 145.5% to -$3.1 million in 2025.
• The last three Retained Earnings figures came in at -$3.1 million (Q4 2025), $3.7 million (Q2 2025), and $6.7 million (Q4 2024), per Business Quant data.